Drug Abuse: Clinical Trials

147 trials for Drug Abuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

107 completed, 18 unknown, 8 withdrawn, 6 recruiting. 60 Not applicable, 17 Phase 1, 14 Phase 2, 8 Phase 3, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable60Completed 41, Unknown 7, Withdrawn 5, Recruiting 4, Not yet recruiting 3
Phase 117Completed 12, Withdrawn 3, Recruiting 1, Terminated 1
Phase 214Completed 13, Withdrawn 1
Phase 38Completed 8
Phase 45Completed 4, Terminated 1
Early Phase 11Unknown 1

Follow Drug Abuse: new trials by email Literature Review of Drug Abuse trials Research Report on Drug Abuse

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Oral THC and CBD in Men and Women
Placebo, THC, CBD - Drug Abuse, Intoxication by Drug
Phase 1RecruitingUniversity of California, Los Angeles222026-08-132026-09-08
Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial
harm reduction intervention in non-clinical anabolic-androgenic steroids users - Drug Abuse, Harm Reduction
Not applicableNot yet recruitingUniversity of Sao Paulo322026-08-012026-07-16
General Well-being After Quitting Drug Use
Physical well-being, Physico-social well-being - Drug Abuse
Not yet recruitingAlanya Alaaddin Keykubat University1202026-07-012026-06-11
Team-based Learning Intervention to Prevent Risk Factors for Chronic Diseases - a Cluster Randomized Trial
Team-based learning - Cardiovascular Diseases, Obesity Prevention
Not applicableNot yet recruitingProfessor Fernando Figueira Integral Medicine Institute2402025-09-012025-03-30
Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD
Personally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME), Control - Opioid Use Disorder, Pregnancy Related
Not applicableCompletedT. John Winhusen, PhD1312024-06-132025-05-11
OUD Smartphone Services
Contingency management, Cognitive-Behavior Therapy Modules, Peer Contingency Management (CM) Guide - Opioid-Related Disorders, Drug Abuse
Not applicableCompletedWestern Michigan University972024-04-232026-08-25
An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community
questionner - Drug Reaction, Drug Hypersensitivity
CompletedDeraya University3002024-02-182024-08-07
Adapted RPM-08 for Substance Use Disorder in Pakistan
Adapted Relapse Prevention Module (RPM-08), Treatment as Usual (TAU) - Substance Use Disorder (SUD), Drug Abuse
Not applicableCompletedUniversiti Sains Malaysia702024-01-042026-04-27
Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders
Satir group - Drug Abuse, Self Esteem
Not applicableCompletedHong Kong Metropolitan University452023-09-012023-10-23
Peer-led Personalized Support Program
Health-risk behaviors, Theory of planned behavior, Self-determination theory, Assist them to adhere to their schedule of quitting drugs throughout the study period - Health-risk Behaviours, Drug Abuse
Not applicableRecruitingChinese University of Hong Kong2002023-06-302025-05-31
Wakaya: Rising Up for Choctaw Youth Health
Wakaya: Rising Up for Choctaw Youth Curriculum - Obesity, Adolescent, Healthy Nutrition
Not applicableRecruitingUniversity of Washington1762023-04-282026-09-30
AA on Drug Abusers by Nursing Students
AA group, Control group - Drug Abuse
Not applicableUnknownThe Hong Kong Polytechnic University802023-03-202025-04-20
An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD
Previct Drugs - Drug Abuse
Not applicableCompletedKontigo Care AB242023-03-102024-10-08
A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication
Previct Drugs - Drug Abuse
Not applicableCompletedKontigo Care AB482023-02-152025-04-02
Effect of Folic Acid on the Presentation of Nuclear Abnormalities in People With a History Drug Abuse
Folic Acid 5 MG - Drug Abuse, Genotoxicity
Not applicableUnknownCentro Universitario de Tonalá452023-02-012023-02-03
Evaluation of Smoked THC and CBD in Men and Women
Placebo Cannabis, 20 mg CBD Cannabis, 20 mg CBD + 20 mg THC Cannabis - Drug Abuse, Intoxication by Drug
Phase 1CompletedUniversity of California, Los Angeles192022-09-012026-03-20
ASSIST: A Surveillance Study of Illicit Substance Toxicity
Surplus sample toxicology analysis - Overdose, Drug, Drug Use
UnknownNHS Greater Glasgow and Clyde10002022-08-192022-09-19
Neurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use Disorder
Active transcranial Direct Current Stimulation, Sham transcranial Direct Current Stimulation - Alcohol Use Disorder (AUD), Alcohol Abuse
Not applicableNot yet recruitingITAB - Institute for Advanced Biomedical Technologies302021-12-012021-10-26
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
Buprenorphine Injection, Buprenorphine Sublingual Product - Opioid-Related Disorders, Drug Addiction
CompletedT. John Winhusen, PhD712021-06-142026-03-16
Addiction in Intensive Cardiac Care Units
urine test, Fagerström questionnaire, Exhaled carbon monoxide (CO) measurement - Intensive Care Unit Syndrome, Drug Abuse
UnknownAssistance Publique - Hôpitaux de Paris15002021-04-062023-04-18

Showing 20 of 147. Sign in to see all of them.

Narrower conditions

Substance-Related Disorders (147)  ·  Alcoholism (29)  ·  Opioid-Related Disorders (29)  ·  Narcotic-Related Disorders (16)  ·  Depression (8)  ·  Tobacco Use Disorder (8)  ·  Alcohol Drinking (7)  ·  Behavior, Addictive (7)  ·  Anxiety Disorders (6)  ·  Marijuana Abuse (5)  ·  Mental Disorders (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  Adolescent Behavior (4)  ·  Cocaine-Related Disorders (4)  ·  Drug Overdose (4)

Broader conditions

Chemically-Induced Disorders (147)  ·  Mental Disorders (142)  ·  Behavior (33)  ·  Alcohol-Related Disorders (28)  ·  Narcotic-Related Disorders (13)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Behavioral Symptoms (9)  ·  Communicable Diseases (8)  ·  Drinking Behavior (8)  ·  Genital Diseases (8)  ·  Urogenital Diseases (8)  ·  Blood-Borne Infections (7)  ·  Compulsive Behavior (7)  ·  Immune System Diseases (7)  ·  Impulsive Behavior (7)

Interventions

Buprenorphine, Naloxone Drug Combination (6)  ·  Crisis Intervention (6)  ·  Buprenorphine (5)  ·  Therapeutics (5)  ·  Cognitive Behavioral Therapy (4)  ·  Mass Screening (3)  ·  Phentermine (3)  ·  Control Groups (2)  ·  Educational Status (2)  ·  Ethanol (2)  ·  Motivational Interviewing (2)  ·  Naloxone (2)  ·  National Program of Cancer Registries (2)  ·  Referral and Consultation (2)  ·  Urinalysis (2)

Sponsors

National Institute on Drug Abuse (NIDA) (15)  ·  Member Companies of the Opioid PMR Consortium (10)  ·  ER/LA Opioid REMS Program Companies (RPC) (6)  ·  Boston Children's Hospital (4)  ·  Indivior Inc. (4)  ·  T. John Winhusen, PhD (4)  ·  The University of Hong Kong (4)  ·  University of California, Los Angeles (4)  ·  University of Michigan (4)  ·  RAND (3)  ·  University of Florida (3)  ·  University of Washington (3)  ·  Friends Research Institute, Inc. (2)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (2)  ·  Kaiser Permanente (2)

Countries

United States (84)  ·  Hong Kong (6)  ·  Canada (5)  ·  France (4)  ·  Mexico (4)  ·  Norway (4)  ·  United Kingdom (3)  ·  China (2)  ·  Egypt (2)  ·  Israel (2)  ·  Austria (1)  ·  Brazil (1)  ·  India (1)  ·  Netherlands (1)  ·  Pakistan (1)

Top investigators

T. John Winhusen, PhD (4)  ·  Elliot Stein, Ph.D. (3)  ·  Soledad Cepeda, MD, PhD (3)  ·  Alexandra Barsdorf, Ph.D. (2)  ·  Chudley E Werch, PhD (2)  ·  David Cordova, PhD (2)  ·  Frederic C Blow, PhD (2)  ·  Heidi Resnick, Ph.D. (2)  ·  John R. Knight, MD (2)  ·  Kenneth R Petronis (2)  ·  Paul Coplan, MS, ScD, MBA (2)  ·  Robert P Schwartz, M.D. (2)  ·  Theresa Winhusen, PhD (2)  ·  Alane Kimes, Ph.D. (1)

Results publications

PMID 37023858, PMID 20732631, PMID 33605440, PMID 11496122, PMID 12233992, PMID 12507797, PMID 12957348, PMID 17015817, PMID 17950161, PMID 20048226, PMID 20869813, PMID 21184260, PMID 21412231, PMID 21475990, PMID 22004305, PMID 22041255, PMID 22082089, PMID 22151478, PMID 22337616, PMID 22367657, PMID 22657748, PMID 23138961, PMID 23186329, PMID 23253201, PMID 23344135, PMID 23566363, PMID 24043921, PMID 24188797, PMID 24520906, PMID 24788740, PMID 24886786, PMID 24969735, PMID 25096690, PMID 25179753, PMID 25282578, PMID 25419091, PMID 25812927, PMID 25997770, PMID 26011508, PMID 26375411, PMID 26500421, PMID 26542471, PMID 26809204, PMID 26881449, PMID 26979982, PMID 27004905, PMID 27302554, PMID 27604543, PMID 27648525, PMID 27883927

NIH funding

UG1DA013732 (4), R01DA026003 (2), 2016 (1), K23DA048162 (1), R01AA009283 (1), R01AA015323 (1), R01AA016854 (1), R01AA017867 (1), R01DA010777 (1), R01DA011158 (1), R01DA014498 (1), R01DA016764 (1), R01DA019934 (1), R01DA022476 (1), R01DA023099 (1)